Target intelligence / Profile preview

Healthy donor erythrocyte

Molecular classification
Other
01

Overview

Healthy donor erythrocyte population" refers to the **red blood cells collected from individuals without known hematologic or systemic disease**, typically used as a reference or control group in research and clinical studies. These cells are characterized by normal morphology and function and serve as the standard for evaluating changes due to disease states or interventions. The properties of healthy donor erythrocytes—such as deformability, antioxidant capacity, metabolic profile, and susceptibility to storage lesions—can vary based on **donor age**, **sex**, **genetic background** (e.g., G6PD status), and other factors[2][3][4][5]. They are not considered a molecular target like receptors or enzymes but rather represent a biological material for comparison or transfusion purposes.\n\nThis entry is incorrect as a \"therapeutic target\": it describes a population of normal cells rather than an individual molecule/receptor/protein that could be targeted by drugs. It should not be listed among canonical molecular targets such as receptors or enzymes.

Other names
Healthy donor red blood cellNormal donor erythrocyteHealthy RBCDonor RBC
02

Mechanism of action

null (not a therapeutic target; mechanisms relate to physiological function rather than drug action)

03

Biological functions

Oxygen transportCarbon dioxide transportAcid-base balanceMaintenance of blood viscosity
04

Disease associations

Other (used as control/reference in transfusion and hematology studies)
05

Safety considerations

Transfusion reactions if used in transfusion contextTransmission of infectious diseases if not properly screened
06

Interacting drugs

null (erythrocytes themselves are not direct drug targets; however, they can be affected by drugs such as hemolytic agents or those altering red cell metabolism)
07

Biomarkers

Hemoglobin concentrationRed cell indices (MCV, RDW)Markers of hemolysis (bilirubin, LDH)Glucose 6-phosphate dehydrogenase activity[4]

Beyond the preview

Go deeper on Healthy donor erythrocyte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Healthy donor erythrocyte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call